ANTX - AN2 Therapeutics
ANTX is a company, not a closed-end fund. We still track it - notices about it are below - but most of this site is about funds.
Is anyone targeting this fund?
Not right now - Almitas was in this company until May 15, 2026 and has since sold down.
What this means for you
Almitas owned more than 5% of this company and has since sold down below that level, so it no longer has to report its holding.
Nothing is required of you. If a large investor buys in again, the notice appears here the day it is filed.
What happened, and when
-
May 15, 2026
Almitas sold down below 5% and stopped reporting.
Original document → -
Feb 17, 2026
Almitas raised its stake to 5.4% (from 5.2%), as a passive investor.
Original document → -
Nov 14, 2025
Almitas now owns 5.2%, as a passive investor.
Original document →
Details: all notices, events and fund facts
| Date | Investor | Stake | Type of notice |
|---|---|---|---|
| May 15, 2026 | Almitas | 4.1% | Sold down below 5% |
| Feb 17, 2026 | Almitas | 5.4% | Passive investor |
| Nov 14, 2025 | Almitas | 5.2% | Passive investor |
No announcements from the fund on file.
- Run by
- not filed yet
- Fund family
- not filed yet
- Exchange
- Nasdaq
Email me when something new is filed for ANTX
Free. One email per notice or announcement, usually within a day. No password.